2Chun YK, Kim JY, Woo H J, et al. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection [ J ]. Hepatology, 2000, 32 ( 5 ) : 1154-1162.
3Lindh M, Horal P, Dhillon AP, et al. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B [J]. J Viral Hepatol, 2000, 7(4) : 258-267.
4Liaw YF. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy [ J ]. Antivir Ther, 2006, 11 (6) : 669 -679.
5Fan HM, Zhang CL, Ying RS, et al. Relationship between liver pathological characteristics and serum l-IBeAg and HBV-DNA in 1057 patients with chronic hepatitis B [ J ]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 2008, 22(2) : 130-132.
6Fung J, Lai CL, But D, et al. Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management [ J]. Am J Gastroenterol, 2008, 103(6) : 1421-142.
7Ke WM, Xie SB, Yu LN, et al. Delince of serum HBV-DNA and no change apportioned by the same hepatic parenchyma cell volume from hepatitic fibrosis stage 1 to stage 4 during the natural history of chronic hepatitis B [J]. Intervirology, 2008, 51 (4): 235-240.
